We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CEO
451
DELISTED
CNOOC Limited
CEO
| $261K | 0.01% |
2,529
-3,124
| -55% | -$374K |
2014 Q2
5 quarters
|
|
452
Schwab US Large- Cap ETF
SCHX
$73.7B
| $258K | 0.01% |
33,888
+6
| +0% | +$49 |
2014 Q1
6 quarters
|
|
|
RDS.B
453
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $258K | 0.01% |
5,432
+60
| +1% | +$3.23K |
2015 Q2
1 quarter
|
|
454
ResMed
RMD
$33.6B
| $257K | 0.01% |
5,050
-3,000
| -37% | -$161K |
2013 Q2
9 quarters
|
|
455
Chord Energy
CHRD
$8.45B
| $256K | 0.01% |
29,472
-4,377
| -13% | -$45.8K |
2013 Q2
9 quarters
|
|
456
PEDEVCO
PED
$182M
| $254K | 0.01% |
5,086
+92
| +2% | +$6.31K |
2013 Q3
8 quarters
|
|
457
iShares Russell 1000 Growth ETF
IWF
$124B
| $249K | 0.01% |
10,724
+1,096
| +11% | +$27K |
2015 Q2
1 quarter
|
|
458
iShares MSCI Malaysia ETF
EWM
$254M
| $248K | 0.01% |
6,250
-2,840
| -31% | -$124K |
2013 Q2
9 quarters
|
|
459
TJX Companies
TJX
$162B
| $248K | 0.01% |
6,936
+18
| +0.3% | +$631 |
2015 Q2
1 quarter
|
|
|
MHG
460
DELISTED
Marine Harvest ASA
MHG
| $247K | 0.01% |
19,565
-1,675
| -8% | -$20.2K |
2014 Q3
4 quarters
|
|
461
SK Telecom
SKM
$12.3B
| $246K | 0.01% |
6,131
-1,102
| -15% | -$43K |
2015 Q1
2 quarters
|
|
462
Consolidated Edison
ED
$41.5B
| $244K | ﹤0.01% |
3,650
-207
| -5% | -$13.1K |
2014 Q1
6 quarters
|
|
463
HP
HPQ
$27.1B
| $244K | ﹤0.01% |
20,967
-5,149
| -20% | -$66.9K |
2013 Q4
7 quarters
|
|
464
Xcel Energy
XEL
$47.7B
| $244K | ﹤0.01% |
6,893
| – | – |
2015 Q2
1 quarter
|
|
|
WFM
465
DELISTED
Whole Foods Market Inc
WFM
| $244K | ﹤0.01% |
7,700
-334
| -4% | -$11.8K |
2013 Q2
9 quarters
|
|
466
Citigroup
C
$208B
| $243K | ﹤0.01% |
4,899
+71
| +1% | +$3.88K |
2013 Q2
9 quarters
|
|
|
CSII
467
DELISTED
Cardiovascular Systems, Inc.
CSII
| $243K | ﹤0.01% |
15,330
| – | – |
2014 Q3
4 quarters
|
|
468
American Electric Power
AEP
$69.2B
| $240K | ﹤0.01% |
4,216
-1,996
| -32% | -$111K |
2013 Q2
9 quarters
|
|
469
Distribution Solutions Group
DSGR
$1.62B
| $240K | ﹤0.01% |
22,136
| – | – |
2013 Q2
9 quarters
|
|
470
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $240K | ﹤0.01% |
+8,775
| New | +$255K |
2015 Q3
0 quarters
|
|
471
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.52B
| $240K | ﹤0.01% |
4,166
+150
| +4% | +$9.19K |
2014 Q1
6 quarters
|
|
472
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $239K | ﹤0.01% |
6,046
| – | – |
2013 Q2
9 quarters
|
|
|
HDP
473
DELISTED
Hortonworks, Inc.
HDP
| $236K | ﹤0.01% |
10,800
-900
| -8% | -$22.3K |
2014 Q4
3 quarters
|
|
|
HSEA.CL
474
DELISTED
HSBC Holdings plc
HSEA.CL
| $234K | ﹤0.01% |
9,000
| – | – |
2013 Q2
9 quarters
|
|
475
Ford
F
$49.6B
| $232K | ﹤0.01% |
+17,070
| New | +$244K |
2015 Q3
0 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.